Filtered By:
Source: The Annals of Thoracic Surgery
Condition: Atrial Fibrillation
Procedure: Gastroschisis Repair

This page shows you your search results in order of date.

Order by Relevance | Date

Total 8 results found since Jan 2013.

Robotic-Assisted Surgical Ablation of Atrial Fibrillation Combined with Mitral Valve Surgery
ConclusionsSurgical AF ablation using robotic-assistance in the setting of mitral valve surgery showed excellent safety and favorable long-term clinical outcomes.
Source: The Annals of Thoracic Surgery - October 12, 2018 Category: Cardiovascular & Thoracic Surgery Source Type: research

Surgical Ablation of Atrial Fibrillation in the United States: Trends and Propensity Matched Outcomes
Conclusions Contemporary utilization of SA is increasing across all operative categories. Performance of SA is accompanied by a 30-day reduction in mortality and stroke. These findings further refine our understanding of the role of SA in the treatment of AF.
Source: The Annals of Thoracic Surgery - July 20, 2017 Category: Cardiovascular & Thoracic Surgery Source Type: research

The Society of Thoracic Surgeons Mitral Valve Repair/Replacement Plus Coronary Artery Bypass Grafting Composite Score: A Report of The Society of Thoracic Surgeons Quality Measurement Task Force
Conclusions An STS composite performance measure was developed for MVRR + CABG operations. This measure may be useful for outcome assessment, quality improvement, patient counseling, clinical research, and public reporting.
Source: The Annals of Thoracic Surgery - December 6, 2016 Category: Cardiovascular & Thoracic Surgery Source Type: research

What Is the Role of Minimally Invasive Mitral Valve Surgery in High-Risk Patients? A Meta-Analysis of Observational Studies
Conclusions Minimally invasive mitral valve surgery is a safe and comparable alternative to standard sternotomy in patients at high risk, with similar early mortality and repair rate and better postoperative outcomes, although a longer cardiopulmonary bypass time is required.
Source: The Annals of Thoracic Surgery - October 24, 2015 Category: Cardiovascular & Thoracic Surgery Source Type: research

Long-Term Outcomes of the Maze Procedure Combined With Mitral Valve Repair: Risk of Thromboembolism Without Anticoagulation Therapy
Conclusions Adopting appropriate selection criteria for discontinuing anticoagulation therapy, the majority of patients receiving concomitant mitral repair and the Maze procedure can discontinue warfarin with excellent long-term safety profiles.
Source: The Annals of Thoracic Surgery - June 23, 2015 Category: Cardiovascular & Thoracic Surgery Source Type: research

Minimally Invasive Port Access Approach for Reoperations on the Mitral Valve
Conclusions The port access approach can be safely adopted for reoperations on the MV without compromising postoperative mortality or MV function.
Source: The Annals of Thoracic Surgery - May 12, 2015 Category: Cardiovascular & Thoracic Surgery Source Type: research

Variation in Warfarin Thromboprophylaxis After Mitral Valve Repair: Does Equipoise Exist and Is a Randomized Trial Warranted? ORIGINAL ARTICLES: ADULT CARDIAC
Conclusions At present, half of patients are prescribed warfarin after isolated mitral valve repair in North American cardiac surgical practice which may impact the length of hospital stay. Although patient-level predictors of warfarin prescription exist, center- and surgeon-level variations are prominent. There is a pressing need for a randomized trial both to guide therapy and to ascertain the potential for resource conservation.
Source: The Annals of Thoracic Surgery - May 29, 2013 Category: Cardiovascular & Thoracic Surgery Authors: Suri, R. M., Thourani, V. H., He, X., Brennan, J. M., O'Brien, S. M., Rankin, J. S., Schaff, H. V., Gammie, J. S. Tags: Valve disease ORIGINAL ARTICLES: ADULT CARDIAC Source Type: research

Midterm Results of David Reimplantation in Patients With Connective Tissue Disorder ORIGINAL ARTICLES: ADULT CARDIAC
Conclusions Prophylactic root and valve preservation using David reimplantation is safe and provides excellent midterm effectiveness and low risk of late events except for endocarditis.
Source: The Annals of Thoracic Surgery - January 30, 2013 Category: Cardiovascular & Thoracic Surgery Authors: Svensson, L. G., Blackstone, E. H., Alsalihi, M., Batizy, L. H., Roselli, E. E., McCullough, R., Vivacqua, A., Moran, R. T., Gillinov, A. M., Thamilarasan, M., Griffin, B., Hammer, D. F., Stewart, W. J., Sabik, J. F., Lytle, B. W. Tags: Valve disease ORIGINAL ARTICLES: ADULT CARDIAC Source Type: research